Klinefelter’s syndrome
Klinefelter syndrome, also known as 47,XXY or XXY syndrome, is a genetic condition that occurs in males when they have an extra X chromosome. This additional chromosome can affect physical and cognitive development, as well as fertility. Klinefelter syndrome is named after Dr. Harry Klinefelter, who first described the condition in 1942.
Symptoms[edit]
Individuals with Klinefelter syndrome may exhibit a variety of symptoms, which can vary in severity. Common physical characteristics include tall stature, gynecomastia (enlarged breasts), small testes, and sparse facial and body hair. Some individuals may also experience learning disabilities, delayed speech and language development, and social challenges.
Causes[edit]
Klinefelter syndrome is caused by the presence of an extra X chromosome in males. Normally, males have one X and one Y chromosome (46,XY). In Klinefelter syndrome, there is an additional X chromosome, resulting in a karyotype of 47,XXY. This extra chromosome is typically not inherited and occurs randomly during the formation of reproductive cells.
Diagnosis[edit]
Diagnosing Klinefelter syndrome may involve a physical examination, hormone testing, genetic testing, and imaging studies. A karyotype analysis, which examines the chromosomes, is often used to confirm the presence of the extra X chromosome.
Treatment[edit]
Treatment for Klinefelter syndrome aims to address specific symptoms and may include hormone replacement therapy to increase testosterone levels, speech and language therapy, educational support for learning difficulties, and psychological support. Fertility treatments such as assisted reproductive technologies may also be considered for individuals who wish to have children.
Prognosis[edit]
With appropriate treatment and support, individuals with Klinefelter syndrome can lead healthy and fulfilling lives. Early intervention and ongoing medical care can help manage symptoms and improve quality of life.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian